CBX5 and myeloid sarcoma: As anticipated from the Lo-CBX5 MS patients, inactivation of Cbx5 had an extensive impact on the transcriptome, with a total of 6,478 differentially regulated genes (3,224 up- and 3,248 down-regulated genes twofold or more, adj.